Materials Q2 2020 In the Materials segment, sales in both divisions were considerably below the second quarter of 2019. (XLS:) XLS Factors influencing sales in Q2 2020 – Materials Materials Performance Materials Monomers Volumes (23%) (31%) (14%) Prices (8%) (4%) (13%) Portfolio 4% 4% 5% Currencies (1%) 0% (1%) Sales (28%) (31%) (23%) Sales development was primarily driven by significantly lower volumes in both divisions due to the effects of the corona pandemic, especially in the Performance Materials division. The decrease in sales volumes here was largely attributable to much weaker demand from the automotive industry. Volumes also declined in the consumer goods and construction industries. In the Monomers division, volumes declined for isocyanates in particular. Significantly lower price levels for isocyanates and polyamides in the Monomers division also contributed to the sales decrease. Prices were slightly lower in the Performance Materials division. Sales in both divisions were positively impacted by portfolio effects from the acquisition of Solvay’s integrated polyamide business. Currency effects had a negative impact on sales. Compared with the prior-year quarter, income from operations (EBIT) before special items declined considerably in both divisions, especially in the Monomers division. This was primarily due to lower isocyanate margins on the back of weak demand. EBIT before special items in the Performance Materials division also declined considerably, mainly as a result of lower volumes. (XLS:) XLS Segment data – Materials (Million €) Q2 H1 2020 2019 +/– 2020 2019 +/– a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets Sales to third parties 2,143 2,961 (28%) 5,017 5,892 (15%) of which Performance Materials 1,071 1,562 (31%) 2,602 3,109 (16%) Monomers 1,072 1,399 (23%) 2,415 2,783 (13%) Income from operations before depreciation, amortization and special items 147 506 (71%) 562 999 (44%) Income from operations before depreciation and amortization (EBITDA) 134 495 (73%) 459 986 (53%) Depreciation and amortizationa 236 176 34% 442 346 28% Income from operations (EBIT) (102) 319 . 17 640 (97%) Special items (22) (15) (47%) (112) (17) . EBIT before special items (80) 334 . 129 657 (80%) Assets (June 30) 9,831 9,174 7% 9,831 9,174 7% Investments including acquisitionsb 87 187 (53%) 1,506 321 369% Research and development expenses 41 47 (13%) 86 95 (9%) back next